 SOUTH SAN FRANCISCO, Calif., Oct. 21, 2022 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced seven upcoming poster presentations at The Liver Meeting November 4-8, 2022, hosted by the American Association for the Study of Liver Diseases AASLD. 